News Articles and Montana BioScience Alliance Newsletters
In recognition of her extraordinary contributions, Sharon has been inducted into the Montana Bioscience Hall of Fame, a fitting tribute to her enduring impact on our bioscience community. And to further honor her legacy, we are proud to announce the creation of the Sharon Peterson STEM Scholarship.
Device developed by Missoula company Gaize (gaize.ai) could help to keep people safe at work and on the road.
2M Beta is a 12-week program delivering the foundational and modern skills required to transform influential ideas into thriving businesses. With access to more professional expertise, more state-of-the-art technology and more community resources, C2M Beta was founded with the mission to connect local entrepreneurs to more!
A message from Board President Cynthia Tsai
SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in principle to create a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s extensive manufacturing and global commercial capabilities.
Members of the Montana BioScience Alliance are encouraged to explore the Montana Rural Health Initiative—a significant statewide investment focused on rural care delivery, workforce development, telehealth, and applied clinical innovation. This program offers Alliance companies and research partners a rare chance to access non-dilutive funding, pilot technologies in real clinical settings, and build direct partnerships with Montana healthcare systems and community stakeholders. Just as importantly, it creates a pathway to demonstrate impact while advancing commercialization inside Montana. Backed by the administration of Greg Gianforte, the initiative aligns […]
When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.
Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR
Members of the Montana BioScience Alliance are encouraged to explore the Montana Rural Health Initiative—a significant statewide investment focused on rural care delivery, workforce development, telehealth, and applied clinical innovation. This program offers Alliance companies and research partners a rare chance to access non-dilutive funding, pilot technologies in real clinical settings, and build direct partnerships with Montana healthcare systems and community stakeholders. Just as importantly, it creates a pathway to demonstrate impact while advancing commercialization inside Montana. Backed by the administration of Greg Gianforte, the initiative aligns […]
View the December BIOWire Newsletter now!